Global Consumer Genomics Market Size, Share, and COVID-19 Impact Analysis, By Application (Genetic Relatedness, Diagnostics, Sports Nutrition & Health), By End User (Research Institute, Healthcare facilities, Diagnostic Centers, Pharmaceuticals Company & Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033
Industry: HealthcareGlobal Consumer Genomics Market Insights Forecasts to 2033.
- The Global Consumer Genomics Market Size was Valued at USD 1.33 Billion in 2023.
- The Market Size is Growing at a CAGR of 18.85% from 2023 to 2033.
- The Worldwide Consumer Genomics Market Size is Expected to Reach USD 7.48 Billion by 2033.
- Asia Pacific is expected to Grow the fastest during the forecast period.
Get more details on this report -
The Global Consumer Genomics Market Size is Anticipated to Exceed USD 7.48 Billion by 2033, Growing at a CAGR of 18.85% from 2023 to 2033.
Market Overview
The area of genetics known as genomics makes individual infection risk predictions and adjusts medical treatment accordingly. The foundation of consumer genetics is the idea that every person has a unique DNA and that some genetic variants is predispose a person to specific diseases associated with the sequencing, analysis, and interpretation of an individual's genome. A healthcare professional suggests looking into a certain medical problem. While consumer-driven genetic testing is requested by a healthcare professional in response to an educated patient request, genetic tests is obtained online independently of the healthcare provider. Tests using consumer genomics is reveal how the body assembles particular proteins or uses various nutrients. The many services offered by genetic testing, such as data security, ancestor identification, and race, all support the practice's growing usage in therapeutic contexts. Genetic testing is growing in popularity as a result. Clinical, genealogical, and forensic contexts also use consumer genetic testing. In addition, collaborations between important industry players and substantial product innovation are anticipated to further boost market expansion. For example, 1health.io Inc. greatly increased the scope of its testing capabilities in the direct-to-consumer and clinical domains in July 2022.
Report Coverage
This research report categorizes the market for the global consumer genomics market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global consumer genomics market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global consumer genomics market.
Global Consumer Genomics Market Report Coverage
Report Coverage | Details |
---|---|
Base Year: | 2023 |
Market Size in 2023: | USD 1.33 Billion |
Forecast Period: | 2023 - 2033 |
Forecast Period CAGR 2023 - 2033 : | 18.85% |
2033 Value Projection: | USD 7.48 Billion |
Historical Data for: | 2019 - 2022 |
No. of Pages: | 200 |
Tables, Charts & Figures: | 110 |
Segments covered: | By Application, By End User, By Region. |
Companies covered:: | Amgen, Inc., Ancestry, Biomeb, Color Health, Inc, Diagnomics, Inc., Futura Genetics, Gene By Gene, Ltd. (FamilyTree DNA), Helix OpCo LLC, Illumina, Inc., inui Health (formerly Scanadu), Mapmygenome, Metabolomic Discoveries GmbH, MyHeritage Ltd., Myriad Genetics, Inc, Pathway Genomics, Positive Biosciences, Ltd, QuickCheck Health, SomaLogic, Inc., and Others. |
Pitfalls & Challenges: | COVID-19 Empact, Challenge, Future, Growth, & Analysis |
Get more details on this report -
Driving factor
The global consumer genomics market is driven by various factors, including direct-to-consumer (DTC) kit sales and physician interest, which are driving the market's expansion. Other factors contributing to the market's growth include technological advancements, the growing range of consumer genomics applications, supportive government policies, and the growing trend of personalized genomics. For example, the availability of DTC tests became more widespread in 2022 as anyone could buy them without a prescription, which made them handier and more available to the general public. The market is mostly driven by the growing application areas for direct-to-consumer (DTC) genetic testing. Ancestor identification, race determination, and family relationship research are just a few of the many services that are included in genetic testing. Clinical practices are adopting these varied applications at a higher rate. Additionally, reliable consumer genetics tests are used in the forensic, therapeutic, and genealogy fields. There are several firms that provide DTC testing that is customized for sports, nutrition, continuing research, and other sectors. In addition, through consumer genomics, people learn about their genetic susceptibilities to a range of illnesses and ailments. Customers learn more about their genetic illnesses, cancer susceptibility, and cardiovascular disease risk by having their DNA analyzed. The ability to avoid or control these disorders with more knowledge empowers people, which increases demand for consumer genomics services.
Restraining Factors
There are insufficient serious privacy and security concerns that significantly hamper the consumer genomics market's expansion. Customers could worry that once their genetic data is shared with the healthcare provider, they won't have control over it. Privacy issues have been exacerbated by the consumer genomics industry's lack of openness and control over data methods.
Market Segmentation
The Global Consumer Genomics Market share is classified into application and end user.
- The genetic relatedness segment is expected to hold the largest share of the global consumer genomics market during the forecast period.
Based on the application, the global consumer genomics market is divided into genetic relatedness, diagnostics, sports nutrition and health. Among these, the genetic relatedness segment is expected to hold the largest share of the global consumer genomics market during the forecast period. The primary driver of this development is the growing use of paternity testing. Revenue creation in this market sector is mostly driven by the increase in demand for maternity, prenatal, and paternity tests. Even though paternity testing kits are easily bought online. At the same time, a sizable percentage of consumers are adopting direct-to-consumer (DTC) genetic testing to find their distant cousins and discover more about their genetic composition.
- The research institute segment is expected to hold the largest share of the global consumer genomics market during the forecast period.
Based on the end user, the global consumer genomics market is divided into research institutes, healthcare facilities, diagnostic centers, Pharmaceuticals Company & others. Among these, the research institute segment is expected to hold the largest share of the global consumer genomics market during the forecast period. A growing number of research institutes report that a variety of firms are now marketing DNA testing as a means of gaining further insights into the health system of the human body.
Regional Segment Analysis of the Global Consumer Genomics Market
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Rest of APAC)
- South America (Brazil and the Rest of South America)
- The Middle East and Africa (UAE, South Africa, Rest of MEA)
North America is anticipated to hold the largest share of the global consumer genomics market over the predicted timeframe.
Get more details on this report -
North America is anticipated to hold the largest share of the global consumer genomics market over the predicted timeframe. A high frequency of the target diseases, high patient awareness levels, and high per capita healthcare spending all support market development. According to data on chronic diseases published by the Centers for Disease Control and Prevention in July 2022, chronic diseases account for the majority of annual deaths and disabilities in the United States. The rising prevalence of chronic illnesses in the nation is conducive to the growth of consumer genomics. This significant market share is also attributable to the early commercialization of genomics in North America and the existence of several important DTC test-related firms. Key DTC businesses are present locally, and Americans are highly aware of at-home testing, which supports America's leading position in the worldwide market.
Asia Pacific is expected to grow the fastest during the forecast period. Because there are funds available for long-term research programs and because DTC genetics is becoming more well known, this region has significant development potential. The expansion of the regional market is also being aided by the introduction of new competitors. For instance, the Hong Kong-based consumer genomics business Prenetics Limited sells its products across East and Southeast Asia. In a similar vein, Xcode Life is an Indian consumer genomics startup with a focus on the domestic market.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the global consumer genomics along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
List of Key Companies
- Amgen, Inc.
- Ancestry
- Biomeb
- Color Health, Inc
- Diagnomics, Inc.
- Futura Genetics
- Gene By Gene, Ltd. (FamilyTree DNA)
- Helix OpCo LLC
- Illumina, Inc.
- inui Health (formerly Scanadu)
- Mapmygenome
- Metabolomic Discoveries GmbH
- MyHeritage Ltd.
- Myriad Genetics, Inc
- Pathway Genomics
- Positive Biosciences, Ltd
- QuickCheck Health
- SomaLogic, Inc.
- Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Developments
- In May 2023, the world leader in genomics-based testing for serious diseases, wellness, and health, Genetic Technologies Limited, announced that it has reached a deal to purchase AffinityDNA's direct-to-consumer eCommerce business and distribution rights.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Global Consumer Genomics Market based on the below-mentioned segments:
Global Consumer Genomics Market, By Application
- Genetic Relatedness
- Diagnostics
- Sports Nutrition and Health
Global Consumer Genomics Market, By End User
- Research Institute
- Healthcare Facilities
- Diagnostic Centers
- Pharmaceuticals Company
- Others
Global Consumer Genomics Market, By Region
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- Uk
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
Frequently Asked Questions (FAQ)
-
1. What are consumer genetics?The area of genetics known as genomics makes individualized health danger predictions and modifies medical care correspondingly.
-
2. Which application area dominated the market for consumer genomics?The genetic relatedness segment is expected to hold the largest share of the global consumer genomics market during the forecast period.
-
3. How is the market for consumer genomics growing?By 2033, the size of the global consumer genomics market is expected to surpass USD 7.48 billion, with a compound annual growth rate (CAGR) of 18.85% from 2023 to 2033.
Need help to buy this report?